SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Morbidity and Mortality: 1998 Chartbook on Cardiovascular, Lung and Blood Diseases. National Institutes of Health. National Heart, Lung, and Blood Institute October, 1998.
  • 2
    Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151:9338.
  • 3
    Anderson FA Jr., Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardin NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med. 1991;115:5915.
  • 4
    Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton JL. Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year population-based study. Arch Intern Med. 1998;158:58593.
  • 5
    Heit JA. Venous thromboembolism: disease burdens, outcomes, and risk factors. J Haemost Thromb. 2005;3:16117.
  • 6
    Anderson FA Jr., Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Prospective study of the impact of continuing medical education and quality assurance programs on use of prophylaxis for venous thromboembolism. Arch Intern Med. 1994;154:66977.
  • 7
    Clagett GP, Anderson FA Jr., Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest. 1995;108:312S34S.
  • 8
    Clagett GP, Anderson FA Jr., Geerts W, et al. Prevention of venous thromboembolism. Chest. 1998;114:531S60S.
  • 9
    Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. Chest. 2004;126:401S28S.
  • 10
    Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thromboembolism with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered in the home. N Engl J Med. 1996;334:6827.
  • 11
    Levine M, Gent M, Hirsch J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med. 1996;334:67781.
  • 12
    Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton JL. Predictors of recurrence after deep vein thrombosis and pulmonary embolism. A population-based cohort study. Arch Intern Med. 2000;160:7618.